Original Medicare (Part A and Part B), Part D, and Medicare Advantage typically offer coverage for the osteoporosis drug Prolia. However, individuals must meet certain requirements for Part B coverage ...
Low back pain can be stubbornly mysterious. For millions of people, the ache persists for years, even when doctors can’t find ...
Alongside the approval of Ponlimsi, the FDA is reviewing a BLA for TEV-45779, a biosimilar candidate for Xolair, covering all currently approved indications.
Treatment with biologic or targeted synthetic disease-modifying antirheumatic drugs failed to mitigate bone mineral density ...
The US Food and Drug Administration (FDA) has added a boxed warning to the label of the osteoporosis drug denosumab (Prolia) about increased risk for severe hypocalcemia in patients with advanced ...
Prevention of osteoporosis should be considered before a bone break occurs, and many patients at risk for the chronic bone condition may benefit from pharmacologic options. "Most current guidelines ...
Osteoporosis — a significant drop in bone density — can lead to fractures and disability if left untreated. Here are ways to ...
For millions of women who have the bone-thinning disease osteoporosis, researchers are reporting that Fosamax, the drug most commonly used worldwide to improve bone density and prevent fractures, can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results